발행물

논문
특허
저서
컨퍼런스

전체 논문

129

21

Wnt signaling promotes tumor development in part through phosphofructokinase 1 platelet isoform upregulation.
Jeon SM, Lim JS, Park SH, Lee JH
Oncol Rep, 2021

22

Innate immune response orchestrates phosphoribosyl pyrophosphate synthetases to support DNA repair.
Liu R, Li J, Shao J, Lee JH, Qiu X, Xiao Y, Zhang B, Hao Y, Li M, Chen Q
Cell Metab, 2021

23

Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets.
Liu R*, Lee JH*, Li J, Yu R, Tan L, Xia Y, Zheng Y, Bian XL, Lorenzi PL, Chen Q, Lu Z
Mol Cell, 2021

24

PFK activation is essential for the odontogenic differentiation of human dental pulp stem cells.
Jeon SM, Lim JS, Kim HR, Lee JH
Biochem Biophys Res Commun, 2021

25

E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair.
Mun JY, Baek SW, Park WY, Kim WT, Kim SK, Roh YG, Jeong MS, Yang GE, Lee JH, Chung JW, Choi YH, Chu IS, Leem SH
Int J Mol Sci, 2020

26

β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion.
Du L*, Lee JH*, Jiang H, Wang C, Wang S, Zheng Z, Shao F, Xu D, Xia Y, Li J, Kim HR, Xing D, Liu P, Lu Z, Lyu J
J Exp Med, 2020

27

The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.
Xu D, Wang Z, Xia Y, Shao F, Xia W, Wei Y, Li X, Qian X, Lee JH, Du L, Zheng Y, Lv G, Leu JS, Wang H, Xing D, Liang T, Hung MC, Lu Z
Nature, 2020

28

Phosphofructokinase 1 Platelet Isoform Promotes β-Catenin Transactivation for Tumor Development.
Lee JH#, Shao F#, Ling J, Lu S, Liu R, Du L, Chung JW, Koh SS, Leem SH, Shao J, Xing D, An Z, Lu Z
Front Oncol, 2020

29

Temozolomide promotes immune escape of GBM cells via upregulating PD-L1.
Wang S, Yao F, Lu X, Li Q, Su Z, Lee JH, Wang C, Du L
Am J Cancer Res, 2019

30

The protein kinase activity of fructokinase A specifies the antioxidant responses of tumor cells by phosphorylating p62.
Xu D, Li X, Shao F, Lv G, Lv H, Lee JH, Qian X, Wang Z, Xia Y, Du L, Zheng Y, Wang H, Lyu J, Lu Z
Sci Adv, 2019